Ludwig-Maximilians-Universität München
print

Language Selection

Breadcrumb Navigation


Content

Societal Challenges Health

Novel Stroma Cell Therapy for Diabetic Kidney Disease (NEPHSTROM)

Project leader: Prof. Hans-Joachim Anders
Institute: Medizinische Klinik und Poliklinik IV, Nephrologie
Function of LMU Munich: Partner
Project participants: 11
Project launch: 1. April 2015, Project end: 31. March 2019, ( Duration: 48 months )
Total funding: 5 994 375 €
Program: Societal Challenges - Demographic Change and Health
Instrument/ funding scheme: Research and Innovation Action (RIA)

RELapses prevENTion in chronic autoimmune disease: common mechanisms and co-morbidities (RELENT)

Project leader: Prof. Hans-Joachim Anders
Institute: Medizinische Klinik und Poliklinik IV, Nephrologie
Function of LMU Munich: Partner
Project participants: 13
Project launch: 1. November 2015, Project end: 30. April 2020, ( Duration: 54 months )
Total funding: 5 999 431 €
Program: Societal Challenges - Demographic Change and Health
Instrument/ funding scheme: Research and Innovation Action (RIA)

Application of omics-based strategies for improved diagnosis and treatment of endocrine hypertension (ENSAT-HT)

Project leader: Prof. Felix Beuschlein
Institute: Medizinische Klinik und Poliklinik IV
Function of LMU Munich: Partner
Project participants: 13
Project launch: 1. April 2015, Project end: 31. March 2020, ( Duration: 60 months )
Total funding: 7 607 337 €
Program: Societal Challenges - Demographic Change and Health
Instrument/ funding scheme: Research and Innovation Action (RIA)

Common mechanisms and pathways in Stroke and Alzheimer's disease. (CoSTREAM)

Project leader: Prof. Martin Dichgans
Institute: Institut für Schlaganfall- und Demenzforschung
Function of LMU Munich: Partner
Project participants: 11
Project launch: 1. December 2015, Project end: 30. November 2020, ( Duration: 60 months )
Total funding: 4 590 185 €
Program: Societal Challenges - Demographic Change and Health
Instrument/ funding scheme: Research and Innovation Action (RIA)

Small Vessel Diseases from a therapeutic perspective: Targets for intervention. Affected pathways and mechanistic exploitation for prevention of stroke dementia (SVDs-at-target)

Project leader: Prof. Martin Dichgans
Institute: Institut für Schlaganfall- und Demenzforschung
Function of LMU Munich: Coordinator
Project participants: 12
Project launch: 1. January 2016, Project end: 31. December 2020, ( Duration: 60 months )
Total funding: 5 998 300 €
Program: Societal Challenges - Demographic Change and Health
Instrument/ funding scheme: Research and Innovation Action (RIA)

Statistical multi-Omics UNDerstanding of Patient Samples (SOUND)

Project leader: Dr. Julien Gagneur
Institute: Gene Center / Department of Biochemistry
Function of LMU Munich: Partner
Project participants: 10
Project launch: 1. September 2015, Project end: 31. August 2018, ( Duration: 36 months )
Total funding: 2 953 063 €
Program: Societal Challenges - Demographic Change and Health
Instrument/ funding scheme: Research and Innovation Action (RIA)

Female cancer prediction using cervical omics and wellbeing screening and prevention (FORECEE)

Project leader: Prof. Nadia Harbeck
Institute: Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Brustzentrum und Onkologische Tagesklinik
Function of LMU Munich: Partner
Project participants: 14
Project launch: 1. September 2015, Project end: 31. August 2019, ( Duration: 48 months )
Total funding: 7 994 754 €
Program: Societal Challenges - Demographic Change and Health
Instrument/ funding scheme: Research and Innovation Action (RIA)

Children’s Liver Tumour European Research Network (ChilTERN)

Project leader: Dr. Beate Häberle
Institute: Kinderchirurgische Klinik und Poliklinik im Dr. von Haunerschen Kinderspital
Function of LMU Munich: Partner
Project participants: 20
Project launch: 1. January 2016, Project end: 31. December 2020, ( Duration: 60 months )
Total funding: 7 941 665 €
Program: Societal Challenges - Demographic Change and Health
Instrument/ funding scheme: Research and Innovation Action (RIA)

European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates (EHVA)

Project leader: Prof. Michael Hölscher
Institute: Tropeninstitut München
Function of LMU Munich: Partner
Project participants: 39
Project launch: 1. January 2016, Project end: 31. December 2020, ( Duration: 60 months )
Total funding: 22 188 521 €
Program: Societal Challenges - Demographic Change and Health
Instrument/ funding scheme: Research and Innovation Action (RIA)

Understanding the dynamic determinants of glucose homeostasis and social capability to promote Healthy and active ageing (DYNAHEALTH)

Project leader: Prof. Berthold Koletzko
Institute: Kinderklinik und Kinderpoliklinik im Dr. von Haunerschen Kinderspital
Function of LMU Munich: Partner
Project participants: 13
Project launch: 1. May 2015, Project end: 30. April 2019, ( Duration: 48 months )
Total funding: 5 917 266 €
Program: Societal Challenges - Demographic Change and Health
Instrument/ funding scheme: Research and Innovation Action (RIA)

Early-life stressors and LifeCycle health (LIFECYCLE)

Project leader: Prof. Berthold Koletzko
Institute: Kinderklinik und Kinderpoliklinik im Dr. von Haunerschen Kinderspital
Function of LMU Munich: Partner
Project participants: 18
Project launch: 1. January 2017, Project end: 31. December 2021, ( Duration: 60 months )
Total funding: 9 957 602 €
Program: Societal Challenges - Demographic Change and Health
Instrument/ funding scheme: Research and Innovation Action (RIA)

Paediatric Inflammatory Bowel Diseases Network for Safety, Efficacy, Treatment and Quality improvement of care (PIBD-SETQuality)

Project leader: Prof. Sibylle Koletzko
Institute: Kinderklinik und Kinderpoliklinik im Dr. von Haunerschen Kinderspital
Function of LMU Munich: Partner
Project participants: 12
Project launch: 1. January 2016, Project end: 31. December 2019, ( Duration: 48 months )
Total funding: 5 996 000 €
Program: Societal Challenges - Demographic Change and Health
Instrument/ funding scheme: Research and Innovation Action (RIA)

Targeting epigenetic REPROGRamming of innate immune cells in Atherosclerosis Management and other chronic inflammatory diseases (REPROGRAM)

Project leader: Prof. Esther Lutgens
Institute: Institut für Prophylaxe und Epidemiologie der Kreislaufkrankheiten
Function of LMU Munich: Partner
Project participants: 11
Project launch: 1. January 2016, Project end: 31. December 2019, ( Duration: 48 months )
Total funding: 6 000 000 €
Program: Societal Challenges - Demographic Change and Health
Instrument/ funding scheme: Research and Innovation Action (RIA)

Paraplegia Prevention in Aortic Aneurysm Repair by Thoracoabdominal Staging with ‘Minimally- Invasive Segmental Artery Coil-Embolization’: A Randomized Controlled Multicentre Trial (PAPA-ARTIS)

Project leader: Dr. Maximilian Lühr
Institute: Herzchirurgische Klinik und Poliklinik
Function of LMU Munich: Partner
Project participants: 20
Project launch: 1. January 2017, Project end: 31. December 2021, ( Duration: 60 months )
Total funding: 5 997 286 €
Program: Societal Challenges - Demographic Change and Health
Instrument/ funding scheme: Research and Innovation Action (RIA)

Aging Lungs in European Cohorts (ALEC)

Project leader: Prof. Dennis Nowak
Institute: Institut und Poliklinik für Arbeits-, Sozial- und Umweltmedizin
Function of LMU Munich: Partner
Project participants: 11
Project launch: 1. April 2015, Project end: 31. March 2019, ( Duration: 48 months )
Total funding: 5 534 095 €
Program: Societal Challenges - Demographic Change and Health
Instrument/ funding scheme: Research and Innovation Action (RIA)

Characterizing Atrial Fibrillation by Translating its Causes into Health Modifiers in the Elderly (CATCH ME)

Project leader: Dr. Moritz Sinner
Institute: Medizinische Klinik und Poliklinik I
Function of LMU Munich: Partner
Project participants: 9
Project launch: 1. May 2015, Project end: 30. April 2019, ( Duration: 48 months )
Total funding: 4 944 773 €
Program: Societal Challenges - Demographic Change and Health
Instrument/ funding scheme: Research and Innovation Action (RIA)

Personalized Risk Assessment in Febrile Illness to Optimise Reallife Management across the European Union (PERFORM)

Project leader: Dr. Ulrich von Both
Institute: Klinik für Kinderheilkunde & Jugendmedizin
Function of LMU Munich: Partner
Project participants: 18
Project launch: 1. January 2016, Project end: 31. December 2020, ( Duration: 60 months )
Total funding: 17 997 665 €
Program: Societal Challenges - Demographic Change and Health
Instrument/ funding scheme: Research and Innovation Action (RIA)